Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Neurocritical Care
Published in: Neurocritical Care 2/2015

01-04-2015 | Original Article

Kidney-Brain Link in Traumatic Brain Injury Patients? A preliminary report

Authors: Celeste Dias, A. Rita Gaio, Elisabete Monteiro, Silvina Barbosa, António Cerejo, Joseph Donnelly, Óscar Felgueiras, Peter Smielewski, José-Artur Paiva, Marek Czosnyka

Published in: Neurocritical Care | Issue 2/2015

Login to get access

Abstract

Background

Kidney hyperfiltration with augmented renal clearance is frequently observed in patients with traumatic brain injury. The aim of this study is to report preliminary findings about the relationship between brain autoregulation impairment, estimated kidney glomerular filtration rate and outcome in critically ill patients after severe traumatic brain injury.

Methods

Data collected from a cohort of 18 consecutive patients with severe traumatic brain injury managed with ICP monitoring in a Neurocritical Care Unit, were retrospectively analyzed. Early morning blood tests were performed for routine chemistry assessments and we analyzed creatinine and estimated creatinine clearance, osmolarity, and sodium. Daily norepinephrine dose, protein intake, and water balance were documented. Time average of brain monitoring data (intracranial pressure, cerebral perfusion pressure, and cerebrovascular reactivity pressure index—PRx) were calculated for 6 h before blood sample tests. Patient outcome was evaluated using Glasgow outcome scale at 6-month follow-up, considering nonfatal outcome if GOS ≥3 and fatal outcome if GOS <3. Multiple linear regression models were used to study the crude and adjusted effects of the above variables on PRx throughout time.

Results

A total of 199 complete daily observations from 18 adult consecutive multiple trauma patients with severe traumatic brain injury were analyzed. At hospital admission, the median post-resuscitation Glasgow coma score was 6 (range 3–12), mean SAPSII score was 44.65 with predicted mortality of 36 %. Hospital mortality rate was 27 % and median GOS at 6 month after discharge was 3. Creatinine clearance (CrCl) was found to have a negative correlation with PRx (Pearson correlation—0.82), with statistically significant crude (p < 0.001) and adjusted (p = 0.001) effects. For each increase of 10 ml/min in CrCl (estimated either by the Cockcroft–Gault or by Modification of Diet in Renal Disease Study equations) a mean decrease in PRx of approximately 0.01 was expected. Amongst possible confounders only norepinephrine was shown to have a significant effect. Mean PRx value for outcome fatal status was greater than mean PRx for nonfatal status (p < 0.05), regardless of the model used for the CrCl estimation.

Conclusions

Better cerebral autoregulation evaluated with cerebrovascular PRx is significantly correlated with augmented renal clearance in TBI patients and associates with better outcome.
Literature
1.
Lassen NA. Autoregulation of cerebral blood flow. Circ Res. 1964;15(Suppl):201–4.PubMed
2.
Just A. Mechanisms of renal blood flow autoregulation: dynamics and contributions. Am J Physiol Regul Integr Comp Physiol. 2007;292:R1–17.CrossRefPubMed
3.
Mogi M, Horiuchi M. Clinical interaction between brain and kidney in small vessel disease. Cardiol Res Pract. 2011;2011:306189.PubMedCentralPubMed
4.
O’Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension. 2005;46:200–4.CrossRefPubMed
5.
Ito S, Nagasawa T, Abe M, Mori T. Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular risk. Hypertens Res. 2009;32:115–21.CrossRefPubMed
6.
Nongnuch A, Panorchan K, Davenport A. Brain-kidney crosstalk. Crit Care. 2014;18:1–11.CrossRef
7.
Davenport A. The brain and the kidney-organ cross talk and interactions. Blood Purif. 2008;26:526–36.CrossRefPubMed
8.
Li N, Zhao W-G, Zhang W-F. Acute kidney injury in patients with severe traumatic brain injury: implementation of the acute kidney injury network stage system. Neurocrit Care. 2011;14:377–81.CrossRefPubMed
9.
Udy A, Boots R, Senthuran S, et al. Augmented creatinine clearance in traumatic brain injury. Anesth Analg. 2010;111:1505–10.CrossRefPubMed
10.
Minville V, Asehnoune K, Ruiz S, et al. Increased creatinine clearance in polytrauma patients with normal serum creatinine: a retrospective observational study. Crit Care. 2011;15:R49.CrossRefPubMedCentralPubMed
11.
12.
Ott L, McClain CJ, Gillespie M, Young B. Cytokines and metabolic dysfunction after severe head injury. J Neurotrauma. 1994;11:447–72.CrossRefPubMed
13.
Smielewski P, Czosnyka M, Steiner L, Belestri M, Piechnik S, Pickard JD. ICM+: software for on-line analysis of bedside monitoring data after severe head trauma. Acta Neurochir Suppl. 2005;95:43–9.CrossRefPubMed
14.
Czosnyka M, Smielewski P, Kirkpatrick P, Laing RJ, Menon D, Pickard JD. Continuous assessment of the cerebral vasomotor reactivity in head injury. Neurosurgery. 1997;41:11–7 discussion 7-9.CrossRefPubMed
15.
Aries MJ, Czosnyka M, Budohoski KP, et al. Continuous determination of optimal cerebral perfusion pressure in traumatic brain injury. Crit Care Med. 2012;40:2456–63.CrossRefPubMed
16.
Brain Trauma F, American Association of Neurological S, Congress of Neurological S, et al. Guidelines for the management of severe traumatic brain injury. IX. Cerebral perfusion thresholds. J Neurotrauma. 2007;24(1):S59–64.
17.
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41.CrossRefPubMed
18.
Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–54.CrossRefPubMed
19.
Jennett B, Bond M. Assessment of outcome after severe brain damage: a practical scale. The Lancet. 1975;305:480–4.CrossRef
20.
21.
Rao V, Klepstad P, Losvik O, Solheim O. Confusion with cerebral perfusion pressure in a literature review of current guidelines and survey of clinical practise. Scand J Trauma Resusc Emerg Med. 2013;21:78.CrossRefPubMedCentralPubMed
22.
Udy AA, Baptista JP, Lim NL, et al. Augmented renal clearance in the ICU: results of a multicenter observational study of renal function in critically ill patients with normal plasma creatinine concentrations*. Crit Care Med. 2014;42:520–7.CrossRefPubMed
23.
Delanaye P, Cavalier E, Maillard N, et al. Creatinine: past and present. Ann Biol Clin. 2010;68:531–43.
24.
Baptista JP, Udy AA, Sousa E, et al. A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance. Crit Care. 2011;15:R139.CrossRefPubMedCentralPubMed
25.
Udy AA, Roberts JA, Lipman J. Implications of augmented renal clearance in critically ill patients. Nat Rev Nephrol. 2011;7:539–43.CrossRefPubMed
26.
Udy AA, Roberts JA, Boots RJ, Paterson DL, Lipman J. Augmented renal clearance: implications for antibacterial dosing in the critically ill. Clin Pharmacokinet. 2010;49:1–16.CrossRefPubMed
27.
Shorr AF, Zilberberg MD. Augmented renal clearance: an augmented definition of appropriate antibiotic therapy?*. Crit Care Med. 2014;42:728–9.CrossRefPubMed
28.
Baptista JP, Sousa E, Martins PJ, Pimentel JM. Augmented renal clearance in septic patients and implications for vancomycin optimisation. Int J Antimicrob Agents. 2012;39:420–3.CrossRefPubMed
29.
Minkute R, Briedis V, Steponaviciute R, Vitkauskiene A, Maciulaitis R. Augmented renal clearance—an evolving risk factor to consider during the treatment with vancomycin. J Clin Pharm Ther. 2013;38:462–7.CrossRefPubMed
30.
Loutzenhiser R, Griffin K, Williamson G, Bidani A. Renal autoregulation new perspectives regarding the protective and regulatory roles of the underlying mechanisms. Am J Physiol Regul Integr Comp Physiol. 2006;290:1153–67.CrossRef
31.
Albanese J, Leone M, Garnier F, Bourgoin A, Antonini F, Martin C. Renal effects of norepinephrine in septic and nonseptic patients. Chest. 2004;126:534–9.CrossRefPubMed
32.
Schiller A, Covic A. Kidney and brain-a renal perspective of ‘Les Liaisons Dangereuses’. Nephrol Dial Transplant. 2010;25:1370–3.CrossRefPubMed
33.
Ono M, Arnaoutakis GJ, Fine DM, et al. Blood pressure excursions below the cerebral autoregulation threshold during cardiac surgery are associated with acute kidney injury. Crit Care Med. 2013;41:464–71.CrossRefPubMedCentralPubMed
34.
Oshima K, Mogi M, Horiuchi M. Therapeutic approach for neuronal disease by regulating renin-angiotensin system. Curr Hypertens Rev. 2013;9:99–107.CrossRef
35.
Pedersen TF, Paulson O, Nielsen AH, Strandgaard S. Effect of nephrectomy and captopril on autoregulation of cerebral blood flow in rats. Am J Physiol Heart Circ Physiol. 2003;285:H1097–104.CrossRefPubMed
36.
Nishimura Y, Ito T, Hoe K-L, Saavedra JM. Chronic peripheral administration of the angiotensin II AT1 receptor antagonist Candesartan blocks brain AT1 receptors. Brain Res. 2000;871:29–38.CrossRefPubMed
37.
Sigurdsson ST, Paulson OB, Hoj Nielsen A, Strandgaard S. Bradykinin antagonist counteracts the acute effect of both angiotensin-converting enzyme inhibition and of angiotensin receptor blockade on the lower limit of autoregulation of cerebral blood flow. J Cereb Blood Flow Metab. 2014;34:467–71.CrossRefPubMedCentralPubMed
38.
Gao J, Marc Y, Iturrioz X, Leroux V, Balavoine F, Llorens-Cortes C. A new strategy for treating hypertension by blocking the activity of the brain renin-angiotensin system with aminopeptidase a inhibitors. Clin Sci (Lond). 2014;127:135–48.CrossRef
39.
Rhee CJ, Kibler KK, Easley RB, et al. Renovascular reactivity measured by near-infrared spectroscopy. J Appl Physiol. 2012;113:307–14.CrossRefPubMed
40.
Jones GRD, Lim E-M. The national kidney foundation guideline on estimation of the glomerular filtration rate. Clin Biochem Rev. 2003;24:95–8.PubMedCentral
Metadata
Title
Kidney-Brain Link in Traumatic Brain Injury Patients? A preliminary report
Authors
Celeste Dias
A. Rita Gaio
Elisabete Monteiro
Silvina Barbosa
António Cerejo
Joseph Donnelly
Óscar Felgueiras
Peter Smielewski
José-Artur Paiva
Marek Czosnyka
Publication date
01-04-2015
Publisher
Springer US
Published in
Neurocritical Care / Issue 2/2015
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-014-0045-1

Other articles of this Issue 2/2015

Neurocritical Care 2/2015 Go to the issue

Practical Pearl

A Cause of Atypical Intracranial Subarachnoid Hemorrhage: Posterior Spinal Artery Aneurysms

Original Article

Therapeutic Intravascular Normothermia Reduces The Burden of Metabolic Crisis

Editorial

A Brain–Kidney Connection: The Delicate Interplay of Brain and Kidney Physiology

Original Article

Non-convulsive Status Epilepticus and Non-convulsive Seizures in Neurological ICU Patients

Original Article

Bedside Evaluation of Cerebral Energy Metabolism in Severe Community-Acquired Bacterial Meningitis

Original Article

Predictors of Nosocomial Pneumonia in Intracerebral Hemorrhage Patients: A Multi-center Observational Study